Medigus Ltd. Series C Warrant
MDGSW
MDGSW was delisted on the 19th of July, 2023.
5 hedge funds and large institutions have $811K invested in Medigus Ltd. Series C Warrant in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more capital invested
Capital invested by funds: $807K → $811K (+$4K)
0% more funds holding
Funds holding: 5 → 5 (0)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$7.1K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.23K |
MDGSW Hedge Fund Activity: Q3 2021 in Review
5 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q3 2021, worth a combined $811K — up 0.5% from $807K a quarter earlier.
Fund positioning in MDGSW was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $2.01K. The largest seller was Warberg Asset Management, cutting an estimated $7.1K.
- 5 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $811K of Medigus Ltd. Series C Warrant stock for Q3 2021, up 0.5% quarter-over-quarter.
- 0 funds opened new Medigus Ltd. Series C Warrant positions in Q3 2021 and 0 closed out.
- The largest Medigus Ltd. Series C Warrant buyer in Q3 2021 was UBS Group, an estimated $2.01K added.
- The largest Medigus Ltd. Series C Warrant seller in Q3 2021 was Warberg Asset Management, an estimated $7.1K sold.
Based on aggregated 13F filings for Q3 2021.